Vagus Nerve Stimulators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2030

 

A vagus nerve stimulator, also known as a brain pacemaker, is a device that generates electrical impulses to stimulate the vagus nerve. These electric impulses travel to the brain and are distributed to various areas to change the activity of nerves, allowing brain cells to function properly. The vagus nerve is a mixed nerve with 20% efferent and 80% afferent fibers. Efferent fibres transmit signals from the brain to the body, whereas afferent fibres are sensory in nature and transport information from the body to the brain. The vagus nerve is the main nerve of the parasympathetic nervous system, which regulates specific involuntary body functions like digestion.

Vagus Nerve Stimulators Market are used to treat chronic conditions such as epilepsy and depression by stimulating the vagus nerve with electrical impulses. VNS is made up of two major parts: a vagus pacemaker and an electrode.

When medications fail to reduce the frequency and severity of seizures, vagal nerve stimulation is used. The vagus nerve is one of many nerves that carry messages to and from the brain. It assists in the regulation of internal organs such as the heart and stomach.

Vagus Nerve Stimulators Market are used to treat chronic conditions such as epilepsy and depression by stimulating the vagus nerve with electrical impulses. VNS is made up of two major parts: a vagus pacemaker and an electrode.

Vagus nerve stimulation (VNS) therapy is used to prevent seizures by sending consistent, mild electrical signals to the brain via the vagus nerve. These pulses are delivered by a device that resembles a pacemaker.

The Vagus Nerve Stimulators Market is a part of the autonomic nervous system that regulates involuntary bodily functions such as heart rate. It travels through the neck, between the chest and abdomen, and to the lower part of the brain. The VNS device, also known as the "pacemaker of the brain," is implanted under the skin on the chest wall. A wire connects it to the vagus nerve in the neck. Vagus nerve stimulators are used to treat intractable epilepsy and treatment-resistant depression.

Key Players

LivaNova PLC, electroCore, Inc., SetPoint Medical Corporation, Beijing PINS Medical Co., Ltd., Parasym Ltd., Nervana, LLC, tVNS Technologies GmbH, BioControl Medical, NeurAxis, Inc., Soterix Medical Inc., MicroTransponder Inc., Boston Scientific Corporation, Cyberonics, Inc.,